Thus, this study aimed to evaluate the potential role of CFHR4 to be a biomarker for HCC diagnosis and/or prognosis, with the expectation of providing novel insights into the tumorigenesis and progression of HCC (5, 43). This evidence concerns the gene CFHR4 and hepatocellular carcinoma.